Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1864 clinical trials
featured
A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers

A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers

lung cancer
nivolumab
adjuvant chemotherapy
cancer chemotherapy
  • 232 views
  • 24 Nov, 2020
  • 1 location
featured
A Randomized, Multicenter, Double Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination with Ipilimumab, or Placebo as Maintenance Therapy in Subjects with Extensive-Stage Disease Small Cell Lung Cancer (SCLC) after Completion of Platinum-based First Line Chemotherapy

Lung Cancer (SCLC) after Completion of Platinum-based First Line Chemotherapy

lung cancer
nivolumab
maintenance therapy
cancer chemotherapy
  • 432 views
  • 23 Nov, 2020
  • 1 location
featured
Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC

Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC

chemoradiotherapy
non-small cell carcinoma
  • 90 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK

lung cancer
lung carcinoma
crizotinib
  • 98 views
  • 23 Nov, 2020
  • 1 location
featured
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

lung cancer
epidermal growth factor
erlotinib
growth factor
lung carcinoma
  • 100 views
  • 23 Nov, 2020
  • 1 location
featured
An Open-Label, Randomized Phase 3 Trial of Nivolumab, or Nivolumab plus Ipilimumab or Nivolumab plus Platinum Doublet Chemotherapy versus Platinum Doublet Chemotherapy in Subjects with Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

Chemotherapy-Naïve Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

lung cancer
nivolumab
platinum doublet
cancer chemotherapy
recurrent non-small cell lung cancer
  • 182 views
  • 23 Nov, 2020
  • 1 location
featured
A Study of Nivolumab plus Ipilimumab in Combination with Chemotherapy vs Chemotherapy alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC)

A Study of Nivolumab plus Ipilimumab in Combination with Chemotherapy vs Chemotherapy alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC)

lung cancer
nivolumab
non-small cell carcinoma
cancer chemotherapy
lung carcinoma
  • 640 views
  • 24 Nov, 2020
  • 1 location
featured
TocAtez-Lung

People with non-small cell lung cancer are asked to participate in a research study being conducted by Northwell Health.  

  • 4 views
  • 02 Aug, 2019
  • 1 location
featured
CheckMate 592: Exploratory study of biomarkers-NSCLC

People with non-small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

  • 22 views
  • 22 Feb, 2019
  • 1 location
featured
Supportive Care in Cancer Cachexia

People with non-small cell lung cancer are asked to participate in a research study being conducted by White Plains Hospital.  

  • 18 views
  • 22 Feb, 2019
  • 1 location